Fear-potentiated startle and light-enhanced startle models in drug discovery.

about

Negative Energy Balance Blocks Neural and Behavioral Responses to Acute Stress by "Silencing" Central Glucagon-Like Peptide 1 Signaling in Rats Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.

P2860

Q30392753-4C456E1F-363E-4320-BC64-C46CBCF74AC0 Q30427268-0F257B20-795A-4AC0-9CDF-88895CE9BC64

P2860

Fear-potentiated startle and light-enhanced startle models in drug discovery.

Item

http://www.wikidata.org/entity/Q50789854

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@en

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@nl

type

Item

label

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@en

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@nl

prefLabel

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@en

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@nl

P1476

Fear-potentiated startle and light-enhanced startle models in drug discovery.

@en

P2093

Berend Olivier

http://www.w3.org/2001/XMLSchema#string

Elisabeth Y Bijlsma

http://www.w3.org/2001/XMLSchema#string

Lucianne Groenink

http://www.w3.org/2001/XMLSchema#string

P2860

The neurobiology of startle.

Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm.

Fear conditioning in virtual reality contexts: a new tool for the study of anxiety.

Fear-potentiated startle: a neural and pharmacological analysis.

The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.

Light-enhanced startle: further pharmacological and behavioral characterization.

Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.

The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.

Auditory thresholds in rats of different age and strain. A behavioral and electrophysiological study.

P304

Unit5.48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/0471141755.PH0548S41

http://www.w3.org/2001/XMLSchema#string

P478

Chapter 5

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221795453

http://www.w3.org/2001/XMLSchema#string

P698

22294228

http://www.w3.org/2001/XMLSchema#string

Fear-potentiated startle and light-enhanced startle models in drug discovery.

about

P2860

P2860

Fear-potentiated startle and light-enhanced startle models in drug discovery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698